New pill could reduce need for steroids in painful muscle condition
NCT ID NCT07266168
Summary
This study is testing whether an oral medication called ivarmacitinib can help control polymyalgia rheumatica (PMR) while reducing the need for steroid medications. The trial will involve 80 adults aged 50-75 with active PMR who will receive either the study drug or a placebo for 12 weeks, followed by longer-term treatment. Researchers want to see if this medication can effectively manage inflammation and pain while allowing patients to use fewer steroids, which often cause significant side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICS (PMR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.